QUOTE AND NEWS
MedPage Today  Feb 3  Comment 
(MedPage Today) -- Usefulness of doxorubicin in embolization doubted
The Economic Times  Feb 1  Comment 
The company expects to increase FY17 revenue by 20% and to bring down debt by the same percentage magnitude.
The Hindu Business Line  Jan 28  Comment 
Construction major HCC has reported 29 per cent decline in net profit for the quarter ending December 31. For the quarter, the net profit was ₹19 crore against ₹27 crore in the comparable quarter of t...
The Hindu Business Line  Oct 30  Comment 
Sadbhav Infrastructure Project Ltd (SIPL) today said it has completed the stake acquisition in Dhule Palesner Tollway Ltd (DPTL) from its JV partners, HCC Concessions (HCON) and JLL.“SIPL h...
The Economic Times  Oct 29  Comment 
Hindustan Construction Company (HCC) today reported over fivefold jump in standalone net profit to Rs 38.44 crore for the quarter ended September 30, on the back of higher turnover.
The Hindu Business Line  Oct 12  Comment 
Hindustan Construction Company (HCC) has bagged a contract worth Rs 942.58 crore from BARC to construct the first phase of its Integrated Nuclear Recycle Plant.“The company has been awarded...
The Hindu Business Line  Oct 11  Comment 
Exit route offered to contractors is an ‘inadequate measure’, says HCC chief
Benzinga  Sep 30  Comment 
Blueprint Medicines (NASDAQ: BPMC) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its novel drug candidate BLU-554 for the treatment of hepatocellular carcinoma (HCC). BLU-554, an...
Forbes  Sep 25  Comment 
Looking at the universe of stocks we cover at Dividend Channel, on 9/29/15, HCC Insurance Holdings, Inc. (NYSE: HCC), Realty Income Corp. (NYSE: O), and EMC Corp. (NYSE: EMC) will all trade ex-dividend for their respective upcoming dividends. HCC...
The Economic Times  Sep 24  Comment 
HCC today said it has bagged a Rs 1,783.42-crore contract from NHAI for construction of a highway in Jammu & Kashmir (J&K).
The Hindu Business Line  Sep 24  Comment 
The Economic Times  Sep 24  Comment 




 

Corporate Overview

Financial Metrics

Revenue Sources

Trends and Forces

T1

T2

T3

Competition

Market Share

References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki